Tag: REMS

iPLEDGE is the FDA's mandatory program to prevent birth defects from isotretinoin. Learn the updated 2026 requirements, what changed in 2023, and how to navigate the system without delays.

Recent-posts

Penicillin Allergies: What Patients Need to Know for Safety

Jan, 23 2026

Heart Disease Risk Factors: Age, Family History, Smoking, and What You Can Do

Nov, 28 2025

How to Tell Opioid Hyperalgesia Apart from Tolerance: Key Clinical Signs

Oct, 30 2025

Complex Generic Formulations: Why Proving Bioequivalence Is So Hard

Aug, 12 2026

Cranberry Juice and Medications: What You Really Need to Know

Feb, 11 2026